Clinical and regulatory-based services to the biopharmaceutical industry.
Edison Ventures contributed strategic guidance that enabled us to shift from a services to a software company, as well as pharma outsourcing best practices
2002 - Edison invests $3.4M and begins to guide the shift from services to software solution selling and productized offering
2004 - Edison adds Jo Webber (Edison Director Network member) to board
2005 - Edison makes $3M follow-on financing
2006 - Edison recruits new investors for $10M financing to spur growth and provide liquidity to founders; Edison makes $3.6M follow-on investment, and adds Chuck Saldarini to the board who subsequently joins the company as interim sales and marketing executive
2012 - $50M in revenue; Edison refers Accenture as acquirer and receives 5X return on exit
Today - Current management providing world-class CRO software and services at Accenture